Accepted at 7:20 p.m. Oct, 31, 2023 by dollajas
Author: Alex
Related Note: 1485313542115
Rationale for change

important to differentiate against buprenorphine here bc as currently written either is correct; both are used in maintenance therapy for detox and, considered opiates, and have the same duration of action (4-8 hrs according to amboss); main difference is partial vs full agonist; amboss "Substance-related and addictive disorders" article supports this

Text Text
Extra Extra
Lecture Notes
Empty field
Missed Questions
Empty field
Pathoma
Empty field
Boards and Beyond
Empty field
First Aid


Sketchy



Watch Opioids, Naloxone, Naltrexone
Sketchy 2
Empty field
Sketchy Extra
Empty field
Picmonic
Empty field
Pixorize

Physeo





Bootcamp
Watch associated Bootcamp video - Opioid Classification
OME

Additional Resources
Empty field
One by one
Empty field
#PANCE::EOR::PSYCH #AK_Step1_v12::#UWorld::Step::18630 #AK_Original_Decks::Step_1::Zanki_Step_Decks::Zanki_Psychiatry_/_Psychology #AK_Step2_v12::#AMBOSS::Ts068h #AK_Step2_v12::#AMBOSS::vs0A9h #AK_Step2_v12::#Resources_by_rotation::Psych::step1_psych_zanki #AK_Step1_v12::#Physeo::09_Pharm::14_Neuro::21_Opioid_Clinical_Use,_Mechanism_and_Overdose #AK_Step1_v12::#UWorld::COMLEX::26722 #AK_Step1_v12::#Bootcamp::Psychiatry::08_Substance_Misuse::04_Opioid_Classification #AK_Step1_v12::^Systems::Psychiatry #AK_Step1_v12::$AnKingUpdates::UWorld #AK_Step1_v12::#FirstAid::13_Psychiatry::02_Pathology::46_Psychoactive_Drug_Intoxication_&_Withdrawal::Depressants::Opioids #AK_Step1_v12::#UWorld::Step::1287 #AK_Step1_v12::#Physeo::^physeo_image_update #PANCE::BEHAVIORAL::substance_use #AK_Step1_v12::#Physeo::09_Pharm::13_Psychiatric::30_Opioid_Withdrawal,_Detoxification_and_Relapse_Prevention #AK_Step1_v12::#Pixorize::^Missing_image !AK_UpdateTags::Step1decks::Zanki-Step-Decks::Zanki-Psychiatry-/-Psychology #AK_Step1_v12::^Other::^HighYield::4-LowerYield #AK_Step1_v12::#AMBOSS::ViaGq4 #AK_Step1_v12::#Pixorize::03_Pharmacology::16_Other_Neuro_Pharm::17_Full_Opioid_Agonists #AK_Step1_v12::#B&B::17_Psych::03_Substance_Use::02_Opioids #AK_Step1_v12::#OME::Clinical::Pediatrics/Psychiatry #AK_Step2_v12::!Shelf::Psych::no_dupes #AK_Step2_v12::Original_decks::Zanki_Step_2::Psych::Step_1_Psych #AK_Step1_v12::#UWorld::COMLEX::24398